tiprankstipranks
Trending News
More News >
Petros Pharmaceuticals (PTPI)
OTHER OTC:PTPI
US Market

Petros Pharmaceuticals (PTPI) Income Statement

Compare
200 Followers

Petros Pharmaceuticals Income Statement

Last quarter (Q3 2025), Petros Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Petros Pharmaceuticals's net income was $-922.72K. See Petros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.11M$ 5.82M$ 5.99M$ 7.81M$ 9.56M
Gross Profit
$ 3.90M$ 4.19M$ 3.70M$ 6.21M$ 5.51M
Operating Expenses
$ 21.58M$ 17.81M$ 23.62M$ 24.26M$ 22.80M
Depreciation and Amortization
$ 2.94M$ 3.42M$ 5.72M$ 6.88M$ 6.75M
EBITDA
$ -10.81M$ -4.21M$ -13.73M$ -1.74M$ -12.21M
Operating Income
$ -17.68M$ -13.62M$ -19.92M$ -18.05M$ -17.28M
Other Income/Expenses
$ 3.36M$ 5.45M$ -121.82K$ 9.06M$ -4.73M
Pretax Income
$ -14.32M$ -8.16M$ -20.04M$ -8.99M$ -22.01M
Net Income
$ -14.32M$ -8.16M$ -20.04M$ -8.99M$ -20.59M
Per Share Metrics
Basic EPS
$ -3.34$ -6.35$ -9.68$ -8.25$ -38.55
Diluted EPS
$ -3.34$ -6.35$ -9.68$ -8.25$ -38.55
Weighted Average Shares Outstanding
8.03M 1.29M 2.07M 1.09M 534.07K
Weighted Average Shares Outstanding (Diluted)
8.03M 2.18M 2.07M 1.09M 534.07K
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History